These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3744385)

  • 21. Boron analysis and boron imaging in biological materials for Boron Neutron Capture Therapy (BNCT).
    Wittig A; Michel J; Moss RL; Stecher-Rasmussen F; Arlinghaus HF; Bendel P; Mauri PL; Altieri S; Hilger R; Salvadori PA; Menichetti L; Zamenhof R; Sauerwein WA
    Crit Rev Oncol Hematol; 2008 Oct; 68(1):66-90. PubMed ID: 18439836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Radiotherapy of high grade glioma: use of fast neutrons, therapy and enhancement by neutron capture].
    Paquis P; Pignol JP; Breteau N
    Neurochirurgie; 2000 Feb; 46(1):23-33. PubMed ID: 10790640
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neutron activation of patients following boron neutron capture therapy of brain tumors at the high flux reactor (HFR) Petten (EORTC Trials 11961 and 11011).
    Wittig A; Moss RL; Stecher-Rasmussen F; Appelman K; Rassow J; Roca A; Sauerwein W
    Strahlenther Onkol; 2005 Dec; 181(12):774-82. PubMed ID: 16362787
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular targeting and treatment of EGFRvIII-positive gliomas using boronated monoclonal antibody L8A4.
    Yang W; Barth RF; Wu G; Kawabata S; Sferra TJ; Bandyopadhyaya AK; Tjarks W; Ferketich AK; Moeschberger ML; Binns PJ; Riley KJ; Coderre JA; Ciesielski MJ; Fenstermaker RA; Wikstrand CJ
    Clin Cancer Res; 2006 Jun; 12(12):3792-802. PubMed ID: 16778107
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EGF-receptor targeted liposomes with boronated acridine: growth inhibition of cultured glioma cells after neutron irradiation.
    Kullberg EB; Wei Q; Capala J; Giusti V; Malmström PU; Gedda L
    Int J Radiat Biol; 2005 Aug; 81(8):621-9. PubMed ID: 16298943
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective radiography of 10B distribution in organs using cold and thermal neutron beams.
    Skvarc J; Giacomelli M; Yanagië H; Kühne G
    Cell Mol Biol Lett; 2002; 7(1):162-4. PubMed ID: 11944078
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular targeting and treatment of composite EGFR and EGFRvIII-positive gliomas using boronated monoclonal antibodies.
    Yang W; Wu G; Barth RF; Swindall MR; Bandyopadhyaya AK; Tjarks W; Tordoff K; Moeschberger M; Sferra TJ; Binns PJ; Riley KJ; Ciesielski MJ; Fenstermaker RA; Wikstrand CJ
    Clin Cancer Res; 2008 Feb; 14(3):883-91. PubMed ID: 18245552
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sensitizing effect of the phosphatidylinositol 3-kinase inhibitor wortmannin on thermal neutron irradiation with or without boron compound.
    Kinashi Y; Sakurai Y; Masunaga S; Takagaki M; Ono K
    Radiat Med; 2001; 19(1):27-32. PubMed ID: 11305615
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intratumoral delivery of boronated epidermal growth factor for neutron capture therapy of brain tumors.
    Yang W; Barth RF; Adams DM; Soloway AH
    Cancer Res; 1997 Oct; 57(19):4333-9. PubMed ID: 9331095
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Toward prompt gamma spectrometry for monitoring boron distributions during extra corporal treatment of liver metastases by boron neutron capture therapy: a Monte Carlo simulation study.
    Khelifi R; Nievaart VA; Bode P; Moss RL; Krijger GC
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S359-61. PubMed ID: 19394243
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Boronated epidermal growth factor as a potential targeting agent for boron neutron capture therapy of brain tumors.
    Capala J; Barth RF; Bendayan M; Lauzon M; Adams DM; Soloway AH; Fenstermaker RA; Carlsson J
    Bioconjug Chem; 1996; 7(1):7-15. PubMed ID: 8741985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular targeting of the epidermal growth factor receptor for neutron capture therapy of gliomas.
    Barth RF; Yang W; Adams DM; Rotaru JH; Shukla S; Sekido M; Tjarks W; Fenstermaker RA; Ciesielski M; Nawrocky MM; Coderre JA
    Cancer Res; 2002 Jun; 62(11):3159-66. PubMed ID: 12036929
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The current status of the boron neutron capture therapy of tumors].
    Spryshkova RA; Iagubov AS; Grigor'eva EIu; Koldaeva EIu
    Vopr Onkol; 1995; 41(2):106-7. PubMed ID: 7483399
    [No Abstract]   [Full Text] [Related]  

  • 34. A method to build an analytic model of the 10B(n,alpha)7Li reaction rate space distribution for boron neutron capture therapy (BNCT).
    Morand J; Moss R; Hachem S; Sauerwein W
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S149-52. PubMed ID: 19375922
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Boronated antibodies for neutron capture therapy.
    Abraham R; Müller R; Gabel D
    Strahlenther Onkol; 1989; 165(2-3):148-51. PubMed ID: 2494718
    [No Abstract]   [Full Text] [Related]  

  • 36. Optimization of boron neutron capture therapy for the treatment of undifferentiated thyroid cancer.
    Dagrosa MA; Thomasz L; Longhino J; Perona M; Calzetta O; Blaumann H; Rebagliati RJ; Cabrini R; Kahl S; Juvenal GJ; Pisarev MA
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1059-66. PubMed ID: 17967301
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Boron neutron capture therapy for cancer.
    Barth RF; Soloway AH; Fairchild RG
    Sci Am; 1990 Oct; 263(4):100-3, 106-7. PubMed ID: 2173134
    [No Abstract]   [Full Text] [Related]  

  • 38. [Boron neutron capture method for the treatment of malignant brain cancer].
    Hatanaka H
    Kango Gijutsu; 1985 Mar; 31(4):519-21. PubMed ID: 3846676
    [No Abstract]   [Full Text] [Related]  

  • 39. Boronated monoclonal antibodies for potential neutron capture therapy of malignant melanoma and leukaemia.
    Tamat SR; Patwardhan A; Moore DE; Kabral A; Bradstock K; Hersey P; Allen BJ
    Strahlenther Onkol; 1989; 165(2-3):145-7. PubMed ID: 2494717
    [No Abstract]   [Full Text] [Related]  

  • 40. Intracellular targeting of sodium mercaptoundecahydrododecaborate (BSH) to solid tumors by transferrin-PEG liposomes, for boron neutron-capture therapy (BNCT).
    Maruyama K; Ishida O; Kasaoka S; Takizawa T; Utoguchi N; Shinohara A; Chiba M; Kobayashi H; Eriguchi M; Yanagie H
    J Control Release; 2004 Aug; 98(2):195-207. PubMed ID: 15262412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.